Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...

The study challenges the ... New Options for Controlling Type 2 Diabetes Apr. 1, 2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Bobbi Conner talks with MUSC's Dr. Remberto Paulo about the symptoms, diagnosis and management of type 1 diabetes in children ...

UNLV researchers are providing free diabetes risk assessments to support the health of the Las Vegas community. Andrew ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

TIX100 is a small molecule inhibitor of TXNIP, a protein involved in cellular stress response and metabolism. This protein ...

The REGENT-1 Australia study found significant improvements in insulin sensitivity and beta cell function after 12 weeks, ...

The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

There were 26.4 deaths per 100,000 people from diabetes, according to early death certificate data for the third quarter of ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...